There was a period not too long ago when Dylan Coleman was viewed as one of the more intriguing relief arms in baseball.
His raw velocity, late movement, and fearless mound presence made him a name that evaluators quietly circled.

During that stretch, opposing front offices were constantly scanning for opportunities to acquire him.
Even fans could envision a scenario where a contender would swoop in, confident that a mechanical tweak or analytical adjustment could unlock something special.

That fear felt especially real before the 2024 season, when whispers grew louder about a potential “buy low” move.
Given Coleman’s struggles in 2023 with the Kansas City organization, the timing felt almost too perfect for a savvy rival.

Coleman’s earlier résumé suggested far more promise than his surface numbers eventually showed.
With the 2022 Royals, he delivered 68 innings of relief work while posting a strong 2.78 ERA and striking out 71 batters.

Those results were not accidental.
Coleman’s fastball routinely flirted with 98 miles per hour, pairing explosiveness with enough deception to overwhelm hitters in short bursts.

However, even in that successful season, warning signs quietly existed beneath the production.
His command was never pristine, as evidenced by the 37 walks he issued, a number that raised long-term concerns among scouts.

Reliever volatility is one of baseball’s harshest truths, and Coleman soon became a textbook example.
What once looked like dominance quickly morphed into unpredictability, with his margin for error shrinking dramatically.

In 2023, everything unraveled.
Across 18 and one-third innings at the major-league level, Coleman posted an alarming 8.84 ERA, struggling to locate his fastball consistently.

The struggles forced the Royals to demote him to Triple-A Omaha, a humbling reset for a pitcher once seen as a late-inning weapon.
While his ERA improved to 4.70 over 30 and two-thirds innings, the inconsistency never truly disappeared.

At that point, Coleman no longer looked like a reliever on the rise.
Instead, he embodied the uncomfortable reality of relief pitching, where small mechanical lapses can cascade into prolonged downturns.

Despite the setbacks, there was a prevailing belief that the right organization could still fix him.
Few teams fit that description better than the Houston Astros, renowned for their pitcher development systems.

Houston’s reputation, heavily influenced by the legacy of Brent Strom, made them an ideal landing spot.
The assumption was simple: if anyone could revive Coleman’s career, it would be the Astros’ pitching lab.

Bizarrely, the experiment produced almost nothing of substance.
Coleman appeared in just one inning for the Astros’ big-league club, albeit a scoreless one that offered brief hope.

The majority of his time was spent with Triple-A Sugar Land, where results were discouraging.
Across 36 appearances, he posted an unsightly 6.50 ERA, failing to reclaim consistency or confidence.

What made the outcome more troubling was the lack of tangible progress.
Velocity, once Coleman’s calling card, showed signs of erosion, reducing his margin for error even further.

After Houston moved on, Coleman attempted to regroup within the Baltimore Orioles minor-league system.
The results were brief and inconclusive, spanning just 11 games before deeper questions emerged.

By that point, Coleman entered the season carrying visible uncertainty.
His fastball velocity had dipped, and his ability to overpower hitters no longer felt like a given.

As the season concluded, his career trajectory seemed to be teetering on the edge.
Once a coveted arm, Coleman now faced the reality of fighting simply to remain relevant in professional baseball.

Over the weekend, however, Coleman made a decisive move.
Rather than fading quietly, he announced that he would be joining the New York Yankees on a minor-league contract.

The announcement itself revealed two notable things simultaneously.
First, Coleman remains genuinely motivated to earn another opportunity at the major-league level.

Second, his excitement about joining the Yankees was palpable.
So much so that he chose to break the news himself, an uncommon move that underscored his enthusiasm.

The signing, while low-risk, fits a familiar Yankees strategy.
New York has increasingly focused on stockpiling depth arms, particularly those with intriguing pasts and minimal financial commitment.

Expecting an immediate breakthrough from Coleman would be unrealistic.
His fastball averaged just 95.7 miles per hour at Triple-A in 2024, a noticeable decline from his peak velocity.

That trend did not reverse during his brief stint in Baltimore’s system.
Without regained velocity or improved command, Coleman faces an uphill battle to crack a major-league bullpen.

Still, the Yankees are not chasing certainty with this move.
They are collecting volume, competition, and potential internal solutions that can emerge organically.

Triple-A innings matter, especially across a long season filled with injuries and fatigue.
Coleman provides coverage, depth, and a theoretical upside that costs the organization virtually nothing.

Realistically, his appearances may be limited to low-leverage situations.
A spring training outing with a modest lead could very well be the most exposure fans see this year.

Even then, anxiety may follow, especially if early control issues resurface.
Those moments, while tense, are precisely why teams take calculated risks like this one.

Not long ago, Houston believed there was something worth salvaging.
Now, the Yankees inherit a delayed opportunity to explore the same question.

Their bullpen remains far from settled, with multiple roles still undefined.
In that uncertainty lies a narrow but real opening for someone like Coleman.

The door is not wide open, but it is no longer closed.
For Dylan Coleman, that alone may be enough to keep the pursuit alive.